M
Maravai LifeSciences Holdings, Inc.
MRVI · NASDAQ · Healthcare · 1.6B
Closing price
$7.44
+3.19% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
2.9×
Enterprise value / EBITDAEV/EBITDA
-12.7×
Free cash flow yieldFCF yield
-6.6%
Return on equityROE
-61.6%
Operating margin
-3.6%
Net debt / EBITDAbalance-sheet strength
1.2×
Interest coverage
-0.2×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.